Press releases

Nightingale Health launches consumer service Livit by Nightingale Health utilizing its at-home testing solution – Mar 31, 2022
Nightingale to publish half-year report for July – December 2021 on 24 February 2022 – Feb 16, 2022
Nightingale’s information security management certification continued with outstanding results in surveillance audit – Jan 20, 2022
Nightingale Home service launched with major Finnish pharmacy chain Yliopiston Apteekki – Dec 22, 2021
Nightingale’s preventative health service launched at Shin-Oyama City Hospital in Japan – Dec 21, 2021
Nightingale expands its Japan laboratory – Dec 17, 2021
Nightingale’s corporate health service piloted at Mitsui headquarters in Tokyo – Nov 18, 2021
Nightingale launches Nightingale Home and Nightingale Pro service models – Nov 15, 2021
Recording of event: An hour with Nightingale – Oct 28, 2021
Nightingale and BioBank Japan to realise personalised medicine and preventative health in Japan – Oct 28, 2021
Invitation to event: An hour with Nightingale – Oct 18, 2021
Fimea inspected Nightingale’s regulatory compliance with the requirements for manufacturer of medical device – Oct 14, 2021
Nightingale receives CE marking for its at-home blood collection kit – Oct 07, 2021
Nightingale to publish Financial Statements Release for financial year July 2020–June 2021 on 15 September 2021 – Sep 07, 2021
Reaktor becomes strategic partner of Nightingale to accelerate international growth – May 04, 2021
Nightingale intends to launch an initial public offering and listing on Nasdaq First North Growth Market Finland – Feb 19, 2021
Nightingale Health Accelerates the Availability of Its At-Home Blood Testing Solution by Launching an Early-Access Pilot for 10,000 Consumers in Finland – Feb 17, 2021
Nightingale Health and Estonian Biobank Agree Strategic Collaboration Aiming to Work Towards Estonian Biobank’s Nationwide Early Disease Prevention in Estonia – Feb 04, 2021
Nightingale Health secured funding of EUR 8.8 million, Leena Niemistö appointed as member of the Board – Jan 20, 2021
Timo Soininen joins Nightingale as Chairman of the Board – Dec 17, 2020
Nightingale Health appoints lead financial advisor to explore different financing options – Oct 27, 2020
Nightingale to roll-out novel preventative solution for COVID-19 enabling safe returns to work post lockdowns – Jul 06, 2020
Nightingale Health’s blood analysis shows great promise for preventative COVID-19 and Pneumonia Risk Detection – Jun 15, 2020
World-leading population-health researchers join Nightingale’s Scientific Advisory Board – Feb 10, 2020
Mr. Yrjö Närhinen becomes an Investor and Strategic Advisor for Nightingale Health to accelerate its international growth – Jan 31, 2020
Nightingale’s advanced blood-testing for consumers begins service in Helsinki – Jan 30, 2020
Nightingale Health takes first step to bring preventative health for 8 billion – rolls out consumer blood testing and mobile app – Nov 21, 2019
Nightingale Health Opens EUR 50-80M Private Placement Round with Carnegie as its Advisor to Bring Nightingale’s Preventative Health Technology to International Markets – Nov 21, 2019
Nightingale Health Announces Strategic Partnership with Kirin and Mitsui to Bring Nightingale’s Internationally Recognised Blood-Testing Services to the Japanese Market – Nov 15, 2019
Nightingale Health and Imperial College London to investigate new indicators of diabetes in the South Asian population – Nov 04, 2019
Research Institute for Olympic Sports collaborates with Nightingale to enhance athletes’ health and performance – Sep 18, 2019
Nightingale Health expands service coverage to the United States – Jun 07, 2019
Nightingale Health collaborates with National University of Singapore to realise the prevention of chronic diseases in South East Asia – May 08, 2019
Nightingale Health receives laboratory accreditation for clinical services – Apr 16, 2019
Nightingale Health to receive EUR 20 million EU-financing to herald a new era of chronic disease prevention – Jan 18, 2019
Finnish blood testing scale-up and health service provider introduce healthcare for the 21 st century – connecting molecular medicine with lifestyle habits – Dec 02, 2018
New technology links chronic inflammation with increased risk of a wide range of diseases and shorter lifespan – Nov 15, 2018
Nightingale chosen as Nordics' Best Health Tech Startup – Nov 08, 2018
Nightingale wins Finnish Startup of the Year Award – Sep 27, 2018
Nightingale Health to provide biomarker analysis for the world’s largest blood-based prospective cohort study in Latin America – Sep 04, 2018
Nightingale Health and UK Biobank announce major initiative to analyse half a million blood samples to facilitate global medical research – Jun 21, 2018
Nightingale Health expands CE marked blood biomarker service with urine, cerebrospinal fluid and umbilical cord blood services – May 15, 2018
Nightingale Health and THL Biobank to accelerate personalized medicine by analyzing 40,000 blood samples – Mar 12, 2018
Nightingale Health announces strategic collaboration with PerkinElmer – Mar 01, 2018
Nightingale Health awarded “Health Innovation” of the Year – Jan 31, 2018
Nightingale Health Shortlisted for Finnish Health Awards 2018 – Dec 11, 2017
Nightingale Awarded as One of the Most Innovative Biotech SMEs in Europe – Nov 24, 2017
Cutting-edge blood analysis service to realize use in healthcare – Oct 05, 2017
Finnish biomedical start-up Nightingale Health obtains CE mark for blood analysis platform – Jul 03, 2017
Oxford University’s Nuffield Department of Population Health and Nightingale Health announce agreement for comprehensive metabolic biomarker profiling – May 08, 2017
Healthcare start up Nightingale invited to solve world’s biggest health problem with the UN and MIT – Feb 17, 2017
Pioneering Healthcare Company changes name from Brainshake to “Nightingale Health” – Feb 17, 2017
Blood Analysis Company Brainshake Closes Funding of €2M Three Months after First Round – Oct 03, 2016
Brainshake Closes €3.5M to Advance Regulatory Approval of Blood Analysis Service – Sep 14, 2016